Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07135427
PHASE4

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

Sponsor: University of Alabama at Birmingham

View on ClinicalTrials.gov

Summary

The goal of this study is to learn whether patients who have a genetic mutation in the genes that cause alpha 1 antitrypsin deficiency also have genetic variation in nearby genes that can increase risk for reduced immune function and respiratory infections. To investigate this hypothesis, we will compare immune responses to the 20-valent pneumococcal conjugate vaccine (PCV20, Pfizer) between participants who have one abnormal copy of the SERPINA1 gene and either no COPD exacerbations, vs those with 2 or more COPD exacerbations in the past year.

Official title: Genetic Variation in IgG as a Mechanism for Immune Deficiency and Exacerbations in AATD

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-09-03

Completion Date

2027-06

Last Updated

2025-11-10

Healthy Volunteers

No

Interventions

BIOLOGICAL

20-valent pneumococcal conjugate vaccine

Administration of PCV20

Locations (1)

University of Alabama at Birmingham

Birmingham, Alabama, United States